Vorasidenib
servier
['pivot,io,i', 'vorasidenib', 'indigo', 'servier']
servier presents transformational data from pivotal phase 3 indigo trial of vorasidenib in recurrent or residual grade 2 idh-mutant diffuse glioma #asco23 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)